BACKGROUND: Stunted development and reduced fecundity of Schistosoma parasites in immunodeficient mice and the impaired ability of human immunodeficiency virus 1 (HIV-1)-infected humans to excrete schistosome eggs have been described. This study explores the effect that HIV-1-associated immunodeficiency has on the excretion of schistosome eggs in a large cohort of coinfected individuals. METHODS: In a cross-sectional survey, urine and stool samples were obtained from and HIV-1 status was determined for 1545 individuals. More extensive data, including quantitative measures of intensity of infection in schistosomiasis and immunodeficiency, were collected in the Mupfure schistosomiasis and HIV longitudinal cohort, composed of 379 participants of whom 154 were coinfected with HIV-1 and Schistosoma parasites. RESULTS: In the cross-sectional survey, the overall prevalence of schistosomiasis was 43.4%, and 26.3% of the participants were infected with HIV-1. Schistosome infections were due to Schistosoma haematobium in 63.6% of cases, S. mansoni in 18.1% of cases, and dual infections in 18.4% of cases. Intensities of Schistosoma infections, measured by the number of eggs excreted and by the level of circulating anodic antigens, did not differ between HIV-1-negative and HIV-1-positive participants coinfected with S. haematobium, S. mansoni, or both. CD4 cell counts were significantly lower in HIV-1-positive participants and in S. mansoni-infected HIV-1-negative participants than in other participants. CONCLUSION: The present study suggests that adult HIV-1-related immunodeficiency does not impair the ability to excrete eggs in low-intensity infection with S. haematobium, S. mansoni, or both and that infection with HIV-1 may not have major implications for diagnosis and surveillance of schistosomiasis.
BACKGROUND: Stunted development and reduced fecundity of Schistosoma parasites in immunodeficientmice and the impaired ability of human immunodeficiency virus 1 (HIV-1)-infectedhumans to excrete schistosome eggs have been described. This study explores the effect that HIV-1-associated immunodeficiency has on the excretion of schistosome eggs in a large cohort of coinfected individuals. METHODS: In a cross-sectional survey, urine and stool samples were obtained from and HIV-1 status was determined for 1545 individuals. More extensive data, including quantitative measures of intensity of infection in schistosomiasis and immunodeficiency, were collected in the Mupfure schistosomiasis and HIV longitudinal cohort, composed of 379 participants of whom 154 were coinfected with HIV-1 and Schistosoma parasites. RESULTS: In the cross-sectional survey, the overall prevalence of schistosomiasis was 43.4%, and 26.3% of the participants were infected with HIV-1. Schistosome infections were due to Schistosoma haematobium in 63.6% of cases, S. mansoni in 18.1% of cases, and dual infections in 18.4% of cases. Intensities of Schistosoma infections, measured by the number of eggs excreted and by the level of circulating anodic antigens, did not differ between HIV-1-negative and HIV-1-positive participants coinfected with S. haematobium, S. mansoni, or both. CD4 cell counts were significantly lower in HIV-1-positive participants and in S. mansoni-infected HIV-1-negative participants than in other participants. CONCLUSION: The present study suggests that adult HIV-1-related immunodeficiency does not impair the ability to excrete eggs in low-intensity infection with S. haematobium, S. mansoni, or both and that infection with HIV-1 may not have major implications for diagnosis and surveillance of schistosomiasis.
Authors: Soledad Colombe; Myung Hee Lee; Peter J Masikini; Lisette van Lieshout; Claudia J de Dood; Pytsje T Hoekstra; Paul L A M Corstjens; Julius Mngara; Govert J van Dam; Jennifer A Downs Journal: Am J Trop Med Hyg Date: 2018-02-01 Impact factor: 2.345
Authors: Jiangmei Yin; Anlan Dai; Tatiana Arango; Ravi S Kasinathan; Robert M Greenberg; Jean D Boyer Journal: Hum Vaccin Immunother Date: 2012-11-01 Impact factor: 3.452
Authors: Jennifer A Downs; Govert J van Dam; John M Changalucha; Paul L A M Corstjens; Robert N Peck; Claudia J de Dood; Heejung Bang; Aura Andreasen; Samuel E Kalluvya; Lisette van Lieshout; Warren D Johnson; Daniel W Fitzgerald Journal: Am J Trop Med Hyg Date: 2012-10-01 Impact factor: 2.345
Authors: Erick M O Muok; Elses W Simiyu; Elizabeth A Ochola; Zipporah W Ng'ang'a; W Evan Secor; Diana M S Karanja; Pauline N M Mwinzi Journal: Am J Trop Med Hyg Date: 2013-05-13 Impact factor: 2.345
Authors: Rutendo B L Zinyama-Gutsire; Charles Chasela; Per Kallestrup; Simbarashe Rusakaniko; Michael Christiansen; Bernard Ngara; Exnevia Gomo; Henrik Ullum; Christian Erikstrup; Hans O Madsen; Babill Stray-Pedersen; Peter Garred; Takafira Mduluza Journal: OMICS Date: 2015-09
Authors: Martin R Jakobsen; Kieran Cashin; Michael Roche; Jasminka Sterjovski; Anne Ellett; Katharina Borm; Jacqueline Flynn; Christian Erikstrup; Maelenn Gouillou; Lachlan R Gray; Nitin K Saksena; Bin Wang; Damian F J Purcell; Per Kallestrup; Rutendo Zinyama-Gutsire; Exnevia Gomo; Henrik Ullum; Lars Ostergaard; Benhur Lee; Paul A Ramsland; Melissa J Churchill; Paul R Gorry Journal: PLoS One Date: 2013-06-18 Impact factor: 3.240
Authors: Rbl Zinyama-Gutsire; E Gomo; P Kallestrup; C Erikstrup; H Ullum; A E Butterworth; S Munyati; T Mduluza Journal: BMC Infect Dis Date: 2009-10-23 Impact factor: 3.090
Authors: Briana D Furch; Simutanyi Mwakamui; Sandie Sianongo; Kanekwa Zyambo; Douglas C Heimburger; John R Koethe; Paul Kelly Journal: Trans R Soc Trop Med Hyg Date: 2022-02-01 Impact factor: 2.455